首页 > 最新文献

Actas urologicas espanolas最新文献

英文 中文
Efecto de la edad, el periodo y la cohorte en la incidencia del cáncer renal en España entre 1990 y 2019: datos del estudio Global Burden of Disease 1990 年至 2019 年间年龄、时期和队列对西班牙肾癌发病率的影响:来自全球疾病负担研究的数据。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2024.02.003

Objective

This study aimed to assess the influence of age, period, and cohort (A-P-C) factors on kidney cancer (KC) incidence trends in Spain from 1990 to 2019.

Methods

Employing data from the Global Burden of Disease Study 2019, we employed joinpoint analysis to determine long-term patterns and A-P-C modelling to quantify net drift, local drift, longitudinal age curves, and rate ratios (RRs) of period and cohort effects.

Results

Over the period 1990-2019, an estimated 142,811 cases of KC were diagnosed in Spain. A consistent upward trend in KC incidence was observed for both men and women, with the male-to-female ratio remaining stable at 2.6. Joinpoint analysis identified three distinct periods for men: An initial period (1990-1995) characterised by a significant increase in rates, a subsequent period (1995-2016) characterised by a slowdown in the rate of increase, and a final period (2016-2019) in which rates have plateaued. In women, 2 time periods were observed: an initial period (1990-2007) in which rates increased significantly, followed by a period of stabilization (2007-2019).

Men born in the early-mid 20th century had a rising KC risk, peaking in the 1960s. Women's risk rose steadily, peaking in the late 1990s.

Conclusion

A-P-C analysis reveals steady KC incidence increase in both genders over three decades. This highlights the need for targeted public health policies and effective prevention strategies.

目的本研究旨在评估1990年至2019年期间年龄、时期和队列(A-P-C)因素对西班牙肾癌(KC)发病趋势的影响。方法利用《2019 年全球疾病负担研究》(Global Burden of Disease Study 2019)的数据,我们采用连接点分析来确定长期模式,并采用 A-P-C 模型来量化净漂移、局部漂移、纵向年龄曲线以及时期和队列效应的比率 (RR)。男性和女性的 KC 发病率均呈持续上升趋势,男女比例稳定在 2.6。连接点分析确定了男性的三个不同时期:最初阶段(1990-1995 年)的特点是发病率显著上升,随后阶段(1995-2016 年)的特点是发病率上升速度放缓,最后阶段(2016-2019 年)的发病率趋于平稳。在女性中,观察到两个时间段:初期(1990-2007 年),发病率大幅上升,随后进入稳定期(2007-2019 年)。结论A-P-C 分析显示,在过去三十年中,男性和女性的 KC 发病率都在稳步上升。这凸显了制定有针对性的公共卫生政策和有效预防策略的必要性。
{"title":"Efecto de la edad, el periodo y la cohorte en la incidencia del cáncer renal en España entre 1990 y 2019: datos del estudio Global Burden of Disease","authors":"","doi":"10.1016/j.acuro.2024.02.003","DOIUrl":"10.1016/j.acuro.2024.02.003","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to assess the influence of age, period, and cohort (A-P-C) factors on kidney cancer (KC) incidence trends in Spain from 1990 to 2019.</p></div><div><h3>Methods</h3><p>Employing data from the Global Burden of Disease Study 2019, we employed joinpoint analysis to determine long-term patterns and A-P-C modelling to quantify net drift, local drift, longitudinal age curves, and rate ratios (RRs) of period and cohort effects.</p></div><div><h3>Results</h3><p>Over the period 1990-2019, an estimated 142,811 cases of KC were diagnosed in Spain. A consistent upward trend in KC incidence was observed for both men and women, with the male-to-female ratio remaining stable at 2.6. Joinpoint analysis identified three distinct periods for men: An initial period (1990-1995) characterised by a significant increase in rates, a subsequent period (1995-2016) characterised by a slowdown in the rate of increase, and a final period (2016-2019) in which rates have plateaued. In women, 2 time periods were observed: an initial period (1990-2007) in which rates increased significantly, followed by a period of stabilization (2007-2019).</p><p>Men born in the early-mid 20th century had a rising KC risk, peaking in the 1960s. Women's risk rose steadily, peaking in the late 1990s.</p></div><div><h3>Conclusion</h3><p>A-P-C analysis reveals steady KC incidence increase in both genders over three decades. This highlights the need for targeted public health policies and effective prevention strategies.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 538-544"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140276048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ensayo clínico aleatorizado: utilización de la luz IMAGE1S (SPIES) vs. luz blanca durante la resección transuretral de tumores vesicales para la prevención de recurrencias, análisis a los 12 meses de seguimiento 随机临床试验:在经尿道膀胱肿瘤切除术中使用 IMAGE1S (SPIES) 光与白光以预防复发,12 个月随访分析。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2023.10.004

Introduction

The improved image resolution of IMAGE1 S technology will increase tumor detection, achieve a greater number of complete resections, and would probably have an impact on the reduction of recurrences.

Aim

The primary objective was to compare the recurrence rates of IMAGE1 S vs. white light during transurethral resection of the bladder; the secondary objective was to compare the complication rates according to Clavien-Dindo at 12 months of follow-up.

Methodolgy

Prospective, randomized 1:1, blinded clinical trial. Recurrence and complication rates according to Clavien-Dindo were analyzed using chi-square/U Mann-Whitney tests, and recurrence-free survival using Kaplan-Meier curves. The European Association of Urology 2021 scoring model was used.

Results

The analysis included 103 participants; 49 were assigned to the IMAGE1 S group and 54 to the white light group. Recurrence rates were 12.2% and 25.9%, respectively (P = .080). The low and intermediate risk group had a lower recurrence rate with IMAGE1 S (7.7% vs. 30.8%, P = .003) and a higher recurrence-free survival with IMAGE1 S (85.2% vs. 62.8% Log Rank: 0.021), with a Hazard Ratio of 0.215 (95% CI: 0.046-0.925). No differences were observed in the high and very high-risk groups. Complications were mostly grade I and rates were similar between both groups (IMAGE1 S 20.4% vs. white light 7.4% P = .083).

Conclusions

There were no differences in the recurrence rates between groups. However, the low and intermediate risk group had a lower recurrence rate with IMAGE1 S. In addition, perioperative complication rates were not higher.

目的主要目的是比较 IMAGE1 S 与白光经尿道膀胱切除术的复发率;次要目的是比较随访 12 个月后根据 Clavien-Dindo 标准得出的并发症发生率。根据克拉维恩-丁多标准对复发率和并发症发生率进行了秩方/U Mann-Whitney检验,并根据卡普兰-梅耶曲线对无复发生存率进行了分析。分析包括 103 名参与者,其中 49 人被分配到 IMAGE1 S 组,54 人被分配到白光组。复发率分别为 12.2% 和 25.9%(P = .080)。低危和中危组使用 IMAGE1 S 的复发率较低(7.7% 对 30.8%,P = .003),使用 IMAGE1 S 的无复发生存率较高(85.2% 对 62.8% Log Rank:0.021),危险比为 0.215(95% CI:0.046-0.925)。在高风险组和极高风险组中未观察到差异。并发症大多为 I 级,两组的发生率相似(IMAGE1 S 20.4% vs. 白光 7.4% P = .083)。此外,围手术期并发症发生率也不高。
{"title":"Ensayo clínico aleatorizado: utilización de la luz IMAGE1S (SPIES) vs. luz blanca durante la resección transuretral de tumores vesicales para la prevención de recurrencias, análisis a los 12 meses de seguimiento","authors":"","doi":"10.1016/j.acuro.2023.10.004","DOIUrl":"10.1016/j.acuro.2023.10.004","url":null,"abstract":"<div><h3>Introduction</h3><p>The improved image resolution of IMAGE1 S technology will increase tumor detection, achieve a greater number of complete resections, and would probably have an impact on the reduction of recurrences.</p></div><div><h3>Aim</h3><p>The primary objective was to compare the recurrence rates of IMAGE1 S vs. white light during transurethral resection of the bladder; the secondary objective was to compare the complication rates according to Clavien-Dindo at 12 months of follow-up.</p></div><div><h3>Methodolgy</h3><p>Prospective, randomized 1:1, blinded clinical trial. Recurrence and complication rates according to Clavien-Dindo were analyzed using chi-square/U Mann-Whitney tests, and recurrence-free survival using Kaplan-Meier curves. The European Association of Urology 2021 scoring model was used.</p></div><div><h3>Results</h3><p>The analysis included 103 participants; 49 were assigned to the IMAGE1 S group and 54 to the white light group. Recurrence rates were 12.2% and 25.9%, respectively (<em>P</em> <!-->=<!--> <!-->.080). The low and intermediate risk group had a lower recurrence rate with IMAGE1 S (7.7% vs. 30.8%, <em>P</em> <!-->=<!--> <!-->.003) and a higher recurrence-free survival with IMAGE1 S (85.2% vs. 62.8% Log Rank: 0.021), with a Hazard Ratio of 0.215 (95% CI: 0.046-0.925). No differences were observed in the high and very high-risk groups. Complications were mostly grade I and rates were similar between both groups (IMAGE1 S 20.4% vs. white light 7.4% <em>P</em> <!-->=<!--> <!-->.083).</p></div><div><h3>Conclusions</h3><p>There were no differences in the recurrence rates between groups. However, the low and intermediate risk group had a lower recurrence rate with IMAGE1 S. In addition, perioperative complication rates were not higher.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 512-520"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136153985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estado de la formación robótica en la residencia de urología: resultados de una encuesta nacional en España 泌尿外科住院医师机器人培训现状:西班牙全国调查结果
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2024.01.015
N. García-Formoso , R. Ballestero Diego , E. Seguí-Moya , E. Herrero Blanco , C. Mercader Barrull , D.A. González-Padilla , J.M. Benejam Gual

Introduction and objective

The increasing number of robotic urological procedures observed in recent years highlights the need to expand training opportunities in robotic surgery. Our objective is to investigate the state of robotic training during urology residency in Spain in order to identify significant deficiencies.

Materials and methods

A 20-item online survey was conducted among urology residents in Spain who were registered in the database of the Residents and Young Urologists Group of the Spanish Association of Urology. The survey assessed subjective opinions, institutional aspects, training resources, and experience regarding robotic surgery. A total of 455 email invitations were sent throughout the year 2021. Descriptive analysis of the responses was performed.

Results

The participation rate reached 30%, with a total of 135 residents. The 52% of respondents lacked access to a robotic system in their institution, of which only 48% could compensate for this deficiency through external rotations. Among those with access to a robotic system, 25% and 23% reported having access to theoretical and practical training, respectively. The existence of a formal training program was low (13%) and 85% of the respondents considered robotic surgery training in Spain to be deficient.

Conclusions

Training for Spanish residents in robotic urological surgery is perceived as inadequate, emphasizing the crucial need for improvement in training programs in this field.

简介和目的近年来,机器人泌尿外科手术的数量不断增加,这凸显了扩大机器人手术培训机会的必要性。我们的目的是调查西班牙泌尿外科住院医师机器人培训的现状,以找出明显的不足之处。材料和方法对西班牙泌尿外科住院医师进行了一项包含 20 个项目的在线调查,这些住院医师已在西班牙泌尿外科协会住院医师和青年泌尿外科医师组的数据库中注册。调查评估了有关机器人手术的主观意见、机构方面、培训资源和经验。2021 年全年共发出 455 封电子邮件邀请。结果参与率达到30%,共有135名住院医师参与。52%的受访者所在机构无法使用机器人系统,其中只有48%的受访者可以通过外部轮转弥补这一不足。在有机会使用机器人系统的受访者中,分别有25%和23%表示有机会接受理论和实践培训。结论西班牙住院医师在机器人泌尿外科方面的培训被认为是不够的,这强调了改进该领域培训计划的迫切需要。
{"title":"Estado de la formación robótica en la residencia de urología: resultados de una encuesta nacional en España","authors":"N. García-Formoso ,&nbsp;R. Ballestero Diego ,&nbsp;E. Seguí-Moya ,&nbsp;E. Herrero Blanco ,&nbsp;C. Mercader Barrull ,&nbsp;D.A. González-Padilla ,&nbsp;J.M. Benejam Gual","doi":"10.1016/j.acuro.2024.01.015","DOIUrl":"10.1016/j.acuro.2024.01.015","url":null,"abstract":"<div><h3>Introduction and objective</h3><p>The increasing number of robotic urological procedures observed in recent years highlights the need to expand training opportunities in robotic surgery. Our objective is to investigate the state of robotic training during urology residency in Spain in order to identify significant deficiencies.</p></div><div><h3>Materials and methods</h3><p>A 20-item online survey was conducted among urology residents in Spain who were registered in the database of the Residents and Young Urologists Group of the Spanish Association of Urology. The survey assessed subjective opinions, institutional aspects, training resources, and experience regarding robotic surgery. A total of 455 email invitations were sent throughout the year 2021. Descriptive analysis of the responses was performed.</p></div><div><h3>Results</h3><p>The participation rate reached 30%, with a total of 135 residents. The 52% of respondents lacked access to a robotic system in their institution, of which only 48% could compensate for this deficiency through external rotations. Among those with access to a robotic system, 25% and 23% reported having access to theoretical and practical training, respectively. The existence of a formal training program was low (13%) and 85% of the respondents considered robotic surgery training in Spain to be deficient.</p></div><div><h3>Conclusions</h3><p>Training for Spanish residents in robotic urological surgery is perceived as inadequate, emphasizing the crucial need for improvement in training programs in this field.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 545-551"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142117600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
¿Por qué es necesario tener una cepa de BCG fabricada en España? 为什么必须在西班牙生产 bcg 菌株?
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2024.01.006
{"title":"¿Por qué es necesario tener una cepa de BCG fabricada en España?","authors":"","doi":"10.1016/j.acuro.2024.01.006","DOIUrl":"10.1016/j.acuro.2024.01.006","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 487-489"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139887350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalencia y manejo de la incontinencia urinaria asociada a cirugía de prolapso órgano pélvico (colposacropexia). Revisión de la literatura 与盆腔器官脱垂手术(COLPOSACROPEXY)相关的尿失禁的发生率和处理。文献综述
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2023.11.005

Introduction

Stress urinary incontinence (SUI) is frequently associated with pelvic organ prolapse (POP) and may occur after its surgical treatment.

Aim

To determine the incidence, risk factors and management of SUI during and after POP surgery through a review of the available literature.

Materials and method

Narrative literature review on the incidence and management of SUI after POP surgery after search of relevant manuscripts indexed in PubMed, EMBASE and Scielo published in Spanish or English between 2013-2023.

Results

Occult SUI is defined as visible urine leakage when prolapse is reduced in patients without SUI symptoms. De novo SUI develops after prolapse surgery without having previously existed. In continent patients, the number needed to treat (NNT) to prevent one case of de novo SUI is estimated to be 9 patients and about 17 to avoid repeat incontinence surgery. In patients with occult UI, the NNT to avoid repeat incontinence surgery is around 7. Patients with POP and concomitant SUI are the group most likely to benefit from combined surgery with a more favorable NNT (NNT 2).

Conclusion

Quality studies on combined surgery for treatment SUI and POP repair are lacking. Continent patients with prolapse should be warned of the risk of de novo SUI, although concomitant incontinence treatment is not currently recommended. Incontinence surgery should be considered on an individual basis in patients with prolapse and SUI.

摘要:应力性尿失禁(SUI)经常与盆腔器官脱垂(POP)有关,并可能在手术治疗后发生。 目的 通过对现有文献的回顾,确定 POP 手术期间和手术后 SUI 的发生率、风险因素和处理方法。材料和方法对 2013-2023 年间发表在西班牙文或英文版 PubMed、EMBASE 和 Scielo 期刊上的相关手稿进行检索,对 POP 手术后 SUI 的发生率和处理方法进行叙述性文献综述。脱垂手术后出现的新发 SUI 之前并不存在。在大便失禁患者中,预防一例新发 SUI 所需的治疗人数(NNT)估计为 9 人,而避免重复尿失禁手术所需的治疗人数(NNT)约为 17 人。对于隐性尿失禁患者,避免重复尿失禁手术的 NNT 约为 7。POP 和伴有 SUI 的患者是最有可能从联合手术中获益的群体,其 NNT 更有利(NNT 2)。尽管目前不推荐同时进行尿失禁治疗,但应提醒脱垂的大洲病人注意新发 SUI 的风险。尿失禁手术应根据脱垂和 SUI 患者的个体情况进行考虑。
{"title":"Prevalencia y manejo de la incontinencia urinaria asociada a cirugía de prolapso órgano pélvico (colposacropexia). Revisión de la literatura","authors":"","doi":"10.1016/j.acuro.2023.11.005","DOIUrl":"10.1016/j.acuro.2023.11.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Stress urinary incontinence (SUI) is frequently associated with pelvic organ prolapse (POP) and may occur after its surgical treatment.</p></div><div><h3>Aim</h3><p>To determine the incidence, risk factors and management of SUI during and after POP surgery through a review of the available literature.</p></div><div><h3>Materials and method</h3><p>Narrative literature review on the incidence and management of SUI after POP surgery after search of relevant manuscripts indexed in PubMed, EMBASE and Scielo published in Spanish or English between 2013-2023.</p></div><div><h3>Results</h3><p>Occult SUI is defined as visible urine leakage when prolapse is reduced in patients without SUI symptoms. De novo SUI develops after prolapse surgery without having previously existed. In continent patients, the number needed to treat (NNT) to prevent one case of de novo SUI is estimated to be 9 patients and about 17 to avoid repeat incontinence surgery. In patients with occult UI, the NNT to avoid repeat incontinence surgery is around 7. Patients with POP and concomitant SUI are the group most likely to benefit from combined surgery with a more favorable NNT (NNT<!--> <!-->2).</p></div><div><h3>Conclusion</h3><p>Quality studies on combined surgery for treatment SUI and POP repair are lacking. Continent patients with prolapse should be warned of the risk of de novo SUI, although concomitant incontinence treatment is not currently recommended. Incontinence surgery should be considered on an individual basis in patients with prolapse and SUI.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 490-496"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139193931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manejo conservador del traumatismo renal de alto grado 高位肾创伤的保守治疗
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2024.01.001

Introduction

Renal trauma is the most common of urological trauma and accounts for up to 5% of all. The AAST scale is the most widely used to assess renal trauma. This study focuses on high-grade trauma, whose treatment has evolved towards a conservative approach, with techniques such as angioembolization. The aim is to describe the evolution in the management of high-grade renal trauma in all patients treated at La Paz University Hospital from 2001 to 2022.

Material and methods

A descriptive retrospective study was conducted on patients treated at the hospital. The study was divided into two periods (2001-2010 and 2011-2022). A total of 285 patients with renal trauma were collected, of which 54 were high grade. The main variable is the type of management, conservative (embolization) or interventional through nephrectomy.

Results

In the completed series, there was a decrease in radical nephrectomy in high-grade renal trauma from 50% to 13.8% over time, with an increase in embolization from 23.1% to 44.8%. In patients with isolated renal trauma, those treated with embolization increased from 28.6% to 69.2%, while those undergoing radical/partial nephrectomy decreased from 42.8% to 7.69%.

Conclusion

The management of renal trauma has evolved over the years in our center. The number of patients treated by embolization has increased, while the number of complications and nephrectomies has decreased.

导言 肾创伤是泌尿外科最常见的创伤,占所有创伤的 5%。AAST 量表被广泛用于评估肾创伤。本研究的重点是高位创伤,其治疗方法已发展为保守疗法,并采用血管栓塞等技术。材料和方法对在拉巴斯大学医院接受治疗的患者进行了描述性回顾研究。研究分为两个时期(2001-2010 年和 2011-2022 年)。共收集了 285 例肾脏外伤患者,其中 54 例为高级别患者。结果在已完成的系列研究中,高位肾创伤的根治性肾切除术随时间推移从50%降至13.8%,而栓塞术从23.1%增至44.8%。在孤立肾创伤患者中,接受栓塞治疗的患者从 28.6% 增加到 69.2%,而接受根治性/部分肾切除术的患者从 42.8% 减少到 7.69%。通过栓塞治疗的患者数量有所增加,而并发症和肾切除术的数量则有所减少。
{"title":"Manejo conservador del traumatismo renal de alto grado","authors":"","doi":"10.1016/j.acuro.2024.01.001","DOIUrl":"10.1016/j.acuro.2024.01.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Renal trauma is the most common of urological trauma and accounts for up to 5% of all. The AAST scale is the most widely used to assess renal trauma. This study focuses on high-grade trauma, whose treatment has evolved towards a conservative approach, with techniques such as angioembolization. The aim is to describe the evolution in the management of high-grade renal trauma in all patients treated at La Paz University Hospital from 2001 to 2022.</p></div><div><h3>Material and methods</h3><p>A descriptive retrospective study was conducted on patients treated at the hospital. The study was divided into two periods (2001-2010 and 2011-2022). A total of 285 patients with renal trauma were collected, of which 54 were high grade. The main variable is the type of management, conservative (embolization) or interventional through nephrectomy.</p></div><div><h3>Results</h3><p>In the completed series, there was a decrease in radical nephrectomy in high-grade renal trauma from 50% to 13.8% over time, with an increase in embolization from 23.1% to 44.8%. In patients with isolated renal trauma, those treated with embolization increased from 28.6% to 69.2%, while those undergoing radical/partial nephrectomy decreased from 42.8% to 7.69%.</p></div><div><h3>Conclusion</h3><p>The management of renal trauma has evolved over the years in our center. The number of patients treated by embolization has increased, while the number of complications and nephrectomies has decreased.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 521-525"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139539123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resultados quirúrgicos en mujeres diagnosticadas de endometriosis profunda con afectación urológica 被诊断为泌尿系统受累的深部子宫内膜异位症妇女的手术治疗效果
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2024.02.002

Introduction

The prevalence of endometriosis is estimated to be about 10% among women of reproductive age. In about 5-10% of these patients, involvement of urological structures will be developed due to deep endometriosis. Urologists should be familiar with the management of these patients, who will require multidisciplinary care with medical and surgical treatment.

Material and methods

Retrospective study of patients diagnosed with deep endometriosis involving urological structures who underwent surgery performed jointly with gynecology and colorectal surgery departments from June 2012 until June 2021 (60 cases). Urologic symptoms were grouped into 3 groupers for subsequent analysis (storage symptoms, voiding symptoms, and low back pain).

Results

Storage symptoms (frequency and urgency) are the most frequent urologic symptoms. Patients with storage symptoms and low back pain showed improvement after surgery. In contrast, patients with voiding symptoms did not improve with surgical treatment.

Conclusions

The prevalence of endometriosis and the likelihood of involving urologic structures require the urologic community to be aware of the pathology.

Patients with storage symptoms will improve following excision of the endometriotic nodules. The need for Partial cystectomies with ureteral reimplantation can be safely performed by laparoscopic or robotic approach, even in previously operated patients, without compromising long-term function.

导言:据估计,子宫内膜异位症在育龄妇女中的发病率约为 10%。其中约有 5-10% 的患者会因深部子宫内膜异位症而累及泌尿系统结构。材料和方法:对 2012 年 6 月至 2021 年 6 月期间与妇科和结直肠外科联合进行手术治疗的深部子宫内膜异位症患者(60 例)进行回顾性研究。泌尿系统症状分为三组(储尿症状、排尿症状和腰痛)进行分析。储尿症状和腰痛患者在术后均有所改善。结论子宫内膜异位症的发病率和累及泌尿系统结构的可能性要求泌尿外科界了解这一病理现象。即使是以前接受过手术的患者,也可以通过腹腔镜或机器人方法安全地进行部分膀胱切除术和输尿管再植术,而不会影响长期功能。
{"title":"Resultados quirúrgicos en mujeres diagnosticadas de endometriosis profunda con afectación urológica","authors":"","doi":"10.1016/j.acuro.2024.02.002","DOIUrl":"10.1016/j.acuro.2024.02.002","url":null,"abstract":"<div><h3>Introduction</h3><p>The prevalence of endometriosis is estimated to be about 10% among women of reproductive age. In about 5-10% of these patients, involvement of urological structures will be developed due to deep endometriosis. Urologists should be familiar with the management of these patients, who will require multidisciplinary care with medical and surgical treatment.</p></div><div><h3>Material and methods</h3><p>Retrospective study of patients diagnosed with deep endometriosis involving urological structures who underwent surgery performed jointly with gynecology and colorectal surgery departments from June 2012 until June 2021 (60 cases). Urologic symptoms were grouped into 3 groupers for subsequent analysis (storage symptoms, voiding symptoms, and low back pain).</p></div><div><h3>Results</h3><p>Storage symptoms (frequency and urgency) are the most frequent urologic symptoms. Patients with storage symptoms and low back pain showed improvement after surgery. In contrast, patients with voiding symptoms did not improve with surgical treatment.</p></div><div><h3>Conclusions</h3><p>The prevalence of endometriosis and the likelihood of involving urologic structures require the urologic community to be aware of the pathology.</p><p>Patients with storage symptoms will improve following excision of the endometriotic nodules. The need for Partial cystectomies with ureteral reimplantation can be safely performed by laparoscopic or robotic approach, even in previously operated patients, without compromising long-term function.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 532-537"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140273983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
¿Por qué los pacientes con derivaciones urinarias tienen un mayor riesgo de fractura ósea? Revisión sistemática sobre los factores de riesgo de osteoporosis y pérdida de densidad mineral ósea en este grupo de pacientes 为什么尿路改道患者的骨折风险会增加?关于该类患者骨质疏松症和骨矿物质密度下降风险因素的系统回顾。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.acuro.2023.11.007

Introduction

Patients undergoing radical cystectomy with urinary diversions (UDs) are at increased risk of bone fractures compared to the general population. Although a loss of bone mineral density (BMD) has been described in patients with UDs, we still do not know with certainty why these patients follow this tendency.

Objective

We performed a systematic review of the available literature to analyze the prevalence of osteoporosis and bone alterations in patients with ileal UD and the possible associated risk factors.

Evidence acquisition

We systematically searched PubMed® and Cochrane Library for original articles published before December 2022 according to PRISMA guidelines.

Evidence synthesis

A total of 394 publications were identified. We selected 12 studies that met the inclusion criteria with 496 patients included. Six of the twelve studies showed decreased BMD values. Prevalence of osteoporosis was specified in three articles, with values ranging from 0% to 36%. Risk factors such as age, sex, body mass index, metabolic acidosis and renal function appear to have an impact on bone tissue reduction, while type of UD, follow-up, 25-hydroxyvitamin D and parathormone had less evidence or contradictory data. The heterogeneity of the studies analyzed could led to interpretation bias.

Conclusions

UDs are associated with multiple risk factors for osteoporosis and bone fractures. Identifying patients at highest risk and establishing diagnostic protocols in routine clinical practice are essential to reduce the risk of fractures and the resulting complications.

引言与普通人群相比,接受根治性膀胱切除术和尿路改道(UD)的患者发生骨折的风险更高。我们对现有文献进行了系统性回顾,分析了回肠UD患者骨质疏松症和骨质改变的发生率以及可能的相关风险因素。证据获取我们根据PRISMA指南,系统检索了PubMed®和Cochrane图书馆2022年12月之前发表的原始文章。我们选择了符合纳入标准的 12 项研究,共纳入 496 名患者。12 项研究中有 6 项显示 BMD 值下降。有三篇文章明确指出了骨质疏松症的患病率,患病率从 0% 到 36% 不等。年龄、性别、体重指数、代谢性酸中毒和肾功能等风险因素似乎对骨组织减少有影响,而尿失禁类型、随访、25-羟维生素 D 和副肾激素的证据较少或数据相互矛盾。结论UDs与骨质疏松症和骨折的多种风险因素相关。识别高危患者并在常规临床实践中制定诊断方案对于降低骨折风险及由此引发的并发症至关重要。
{"title":"¿Por qué los pacientes con derivaciones urinarias tienen un mayor riesgo de fractura ósea? Revisión sistemática sobre los factores de riesgo de osteoporosis y pérdida de densidad mineral ósea en este grupo de pacientes","authors":"","doi":"10.1016/j.acuro.2023.11.007","DOIUrl":"10.1016/j.acuro.2023.11.007","url":null,"abstract":"<div><h3>Introduction</h3><p>Patients undergoing radical cystectomy with urinary diversions (UDs) are at increased risk of bone fractures compared to the general population. Although a loss of bone mineral density (BMD) has been described in patients with UDs, we still do not know with certainty why these patients follow this tendency.</p></div><div><h3>Objective</h3><p>We performed a systematic review of the available literature to analyze the prevalence of osteoporosis and bone alterations in patients with ileal UD and the possible associated risk factors.</p></div><div><h3>Evidence acquisition</h3><p>We systematically searched PubMed® and Cochrane Library for original articles published before December 2022 according to PRISMA guidelines.</p></div><div><h3>Evidence synthesis</h3><p>A total of 394 publications were identified. We selected 12 studies that met the inclusion criteria with 496 patients included. Six of the twelve studies showed decreased BMD values. Prevalence of osteoporosis was specified in three articles, with values ranging from 0% to 36%. Risk factors such as age, sex, body mass index, metabolic acidosis and renal function appear to have an impact on bone tissue reduction, while type of UD, follow-up, 25-hydroxyvitamin<!--> <!-->D and parathormone had less evidence or contradictory data. The heterogeneity of the studies analyzed could led to interpretation bias.</p></div><div><h3>Conclusions</h3><p>UDs are associated with multiple risk factors for osteoporosis and bone fractures. Identifying patients at highest risk and establishing diagnostic protocols in routine clinical practice are essential to reduce the risk of fractures and the resulting complications.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 7","pages":"Pages 497-511"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139191686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tasa de fluctuación del PSA: un indicador prometedor para el cribado del cáncer de próstata PSA 波动率:前列腺癌筛查的一个有前途的指标
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2023.11.008
U. Can , A. Coskun , C. Canakci , B. Simsek , Y. Karaca , K. Sabuncu , O. Akca

Objectives

To evaluate whether PSA fluctuation can be used to predict the risk of prostate cancer.

Materials and methods

The study included 1244 patients who underwent prostate biopsy at Kartal Dr. Lutfi Kirdar City Hospital between 2013 and 2021 (848 in non-cancer; 396 in cancer). The patient's age, last two PSA values (PSA1 and PSA2) within three months before the biopsy, the duration between two PSAs (days), prostate size (g) and PSA density (PSAD) were all recorded. PSA fluctuation rate (PSAfr) was defined as the change rate between two PSA values.

Results

PSAfr was significantly higher in the non-cancer group than in the prostate cancer group (15.2% [20.5] and 9.6% [14.4], P = .019). A simple linear regression was used to examine the relationship between PSAfr and other factors such as age, PSA, PSAD, and prostate volume, but it was shown that these had no effect on PSA fluctuations. ROC analysis revealed a relatively low area under the curve (AUC) for PSAfr (AUC: 0.584 [0.515-0.653]). However, the cut-off value of 12.35% was found to be significant, with a sensitivity of 58% and a specificity of 59% (P = .019). The odds ratio, adjusted for age, PSAD, and PSA2, was calculated as 0.545 (0.33-0.89) using logistic regression analysis to show the relationship between prostate cancer and PSAfr. As a result, those with high PSAfr were found to be 1.83 times less likely to be diagnosed with prostate cancer than those with low fluctuations.

Conclusion

PSAfr could be used in nomograms to predict prostate cancer risk and reduce the number of unnecessary biopsies.

研究纳入了 2013 年至 2021 年期间在 Kartal Dr. Lutfi Kirdar 市医院接受前列腺活检的 1244 名患者(非癌症患者 848 名;癌症患者 396 名)。患者的年龄、活检前三个月内最后两次 PSA 值(PSA1 和 PSA2)、两次 PSA 之间的间隔时间(天数)、前列腺大小(克)和 PSA 密度(PSAD)均被记录在案。结果 非癌症组的 PSAfr 明显高于前列腺癌组(15.2% [20.5] 和 9.6% [14.4],P = .019)。研究人员使用简单的线性回归来检验 PSAfr 与年龄、PSA、PSAD 和前列腺体积等其他因素之间的关系,但结果显示这些因素对 PSA 波动没有影响。ROC分析显示,PSAfr的曲线下面积(AUC)相对较低(AUC:0.584 [0.515-0.653])。不过,12.35% 的临界值具有显著意义,灵敏度为 58%,特异度为 59% (P = .019)。通过逻辑回归分析,计算出经年龄、PSAD 和 PSA2 调整后的几率比为 0.545(0.33-0.89),显示了前列腺癌与 PSAfr 之间的关系。结论 PSAfr 可用于提名图预测前列腺癌风险,减少不必要的活检次数。
{"title":"Tasa de fluctuación del PSA: un indicador prometedor para el cribado del cáncer de próstata","authors":"U. Can ,&nbsp;A. Coskun ,&nbsp;C. Canakci ,&nbsp;B. Simsek ,&nbsp;Y. Karaca ,&nbsp;K. Sabuncu ,&nbsp;O. Akca","doi":"10.1016/j.acuro.2023.11.008","DOIUrl":"10.1016/j.acuro.2023.11.008","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate whether PSA fluctuation can be used to predict the risk of prostate cancer.</p></div><div><h3>Materials and methods</h3><p>The study included 1244 patients who underwent prostate biopsy at Kartal Dr. Lutfi Kirdar City Hospital between 2013 and 2021 (848 in non-cancer; 396 in cancer). The patient's age, last two PSA values (PSA<sub>1</sub> and PSA<sub>2</sub>) within three months before the biopsy, the duration between two PSAs (days), prostate size (g) and PSA density (PSAD) were all recorded. PSA fluctuation rate (PSAfr) was defined as the change rate between two PSA values.</p></div><div><h3>Results</h3><p>PSAfr was significantly higher in the non-cancer group than in the prostate cancer group (15.2% [20.5] and 9.6% [14.4], <em>P</em> <!-->=<!--> <!-->.019). A simple linear regression was used to examine the relationship between PSAfr and other factors such as age, PSA, PSAD, and prostate volume, but it was shown that these had no effect on PSA fluctuations. ROC analysis revealed a relatively low area under the curve (AUC) for PSAfr (AUC: 0.584 [0.515-0.653]). However, the cut-off value of 12.35% was found to be significant, with a sensitivity of 58% and a specificity of 59% (<em>P</em> <!-->=<!--> <!-->.019). The odds ratio, adjusted for age, PSAD, and PSA2, was calculated as 0.545 (0.33-0.89) using logistic regression analysis to show the relationship between prostate cancer and PSAfr. As a result, those with high PSAfr were found to be 1.83 times less likely to be diagnosed with prostate cancer than those with low fluctuations.</p></div><div><h3>Conclusion</h3><p>PSAfr could be used in nomograms to predict prostate cancer risk and reduce the number of unnecessary biopsies.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 470-475"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139187826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La experiencia del cirujano en la re-resección transuretral (RE-RTU) del cáncer de vejiga: un estudio prospectivo 外科医生经尿道膀胱癌切除术(TUR-RTU)的经验:一项前瞻性研究
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2023.10.007
C.N. Fernandes , L. Vale , J.V. Sousa , T.A. Lopes , C.M. Silva , J. Silva

Introduction and objectives

Transurethral resection of bladder tumor (TURBT) is crucial in the treatment of bladder tumors and when incorrectly performed can cause staging mistakes. To avoid these errors, a second resection is recommended in selected cases. The aim of this study is to evaluate the surgeon's ability to predict histologically complete primary resection of newly diagnosed bladder tumors avoiding the need for a second TURBT.

Methods

This is a prospective, observational study involving 47 consecutive patients with newly diagnosed bladder tumors who had previously undergone primary TURBT, and met EAU criteria for second-look TURBT. Second-look TURBT specimens were analyzed for routine histological assessment and compared with the surgeon's impression of the tumor at initial resection.

Results

Of 91 patients submitted to primary TURBT, 47 met the criteria for second-look TURBT. Second-look specimens revealed residual disease in 20.9% of patients and 3 (6.4%) of patients showed upstaging disease. The sensitivity of a senior to detect disease on second-look TURBT in relation to muscle invasion was 75%, and the specificity was 85%.

Conclusions

Second-look TURBT is crucial in the treatment of bladder cancer and cannot be replaced by a surgeon's opinion, so international recommendations should be followed. Supervision of less experienced surgeons is a cornerstone.

简介和目的膀胱肿瘤经尿道切除术(TURBT)是治疗膀胱肿瘤的关键,如果操作不当,可能会导致分期错误。为避免这些错误,建议在选定的病例中进行第二次切除。本研究的目的是评估外科医生预测新诊断的膀胱肿瘤是否能完成组织学上的初次切除,从而避免进行第二次 TURBT 的能力。方法这是一项前瞻性观察研究,涉及 47 名连续的新诊断膀胱肿瘤患者,他们之前都接受过初次 TURBT,并符合 EAU 关于二次 TURBT 的标准。研究人员对二期TURBT标本进行了常规组织学评估分析,并将其与外科医生在初次切除时对肿瘤的印象进行了比较。结果 在91名接受初次TURBT的患者中,有47人符合二期TURBT的标准。20.9%的患者二诊标本显示有残留病灶,3例(6.4%)患者显示有上行病灶。结论二诊 TURBT 对膀胱癌的治疗至关重要,外科医生的意见无法取代,因此应遵循国际建议。对经验不足的外科医生进行指导是基础。
{"title":"La experiencia del cirujano en la re-resección transuretral (RE-RTU) del cáncer de vejiga: un estudio prospectivo","authors":"C.N. Fernandes ,&nbsp;L. Vale ,&nbsp;J.V. Sousa ,&nbsp;T.A. Lopes ,&nbsp;C.M. Silva ,&nbsp;J. Silva","doi":"10.1016/j.acuro.2023.10.007","DOIUrl":"10.1016/j.acuro.2023.10.007","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Transurethral resection of bladder tumor (TURBT) is crucial in the treatment of bladder tumors and when incorrectly performed can cause staging mistakes. To avoid these errors, a second resection is recommended in selected cases. The aim of this study is to evaluate the surgeon's ability to predict histologically complete primary resection of newly diagnosed bladder tumors avoiding the need for a second TURBT.</p></div><div><h3>Methods</h3><p>This is a prospective, observational study involving 47 consecutive patients with newly diagnosed bladder tumors who had previously undergone primary TURBT, and met EAU criteria for second-look TURBT. Second-look TURBT specimens were analyzed for routine histological assessment and compared with the surgeon's impression of the tumor at initial resection.</p></div><div><h3>Results</h3><p>Of 91 patients submitted to primary TURBT, 47 met the criteria for second-look TURBT. Second-look specimens revealed residual disease in 20.9% of patients and 3 (6.4%) of patients showed upstaging disease. The sensitivity of a senior to detect disease on second-look TURBT in relation to muscle invasion was 75%, and the specificity was 85%.</p></div><div><h3>Conclusions</h3><p>Second-look TURBT is crucial in the treatment of bladder cancer and cannot be replaced by a surgeon's opinion, so international recommendations should be followed. Supervision of less experienced surgeons is a cornerstone.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 448-453"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135515731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas urologicas espanolas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1